Federal grant · project grant (b)
This Eda Investment Supports the Advanced Pharmaceutical Manufacturing (APM) Cluster, Led by the Virginia Biotechnology Research Partnership Authority (activation Capital), With Boosting Virginia's Pharmaceutical Industry by Expanding the Domestic Supply Chain for Essential Medicines and Critical Active Pharmaceutical Ingredients (apis). the Projects Funded as Part of This Award Include Expanding a Nascent Pharmaceutical Manufacturing Corridor in Central Virginia Through Investment in New Wet Lab Space, Development of Critical Infrastructure to Sustain Industrial Capacity in Petersburg, and Engagement With Local Business to Enhance the Regional Pharmaceutical Supply Chain. the Project Will Also Catalyze a New Partnership Between Virginia Commonwealth University and Virginia State University to Create New Pathways for Underserved Residents to High-quality Training and Jobs in the Pharmaceutical Industry. Once Implemented, the Investment Will Help Develop and Strengthen Regional Industry Clusters - All While Embracing Economic Equity, Creating Good-paying Jobs, and Enhancing U.s. Competitiveness Globally.
Committed
$2.4 Million
Paid out
$2.2M
92%
Committed, not yet paid
$194.4K
8%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…